TD Global Biotechnology Fund
Fund Profile
Date of Formation: Oct 2 2000 Auditor: Deloitte & Touche LLP
Sales Compensation: Option of Sales Charge or Redemption Charge (Principal) Custodian: Canadian Imperial Bank of Commerce
Investment Fund Type: Foreign Common Shares (Principal) Distributor: TD Investment Services Inc.
Eligible for RRSP: Yes Investment Portfolio Manager: Credit Suisse Asset Management, LLC
Financial Year-End: Dec 31 Trustee: TD Asset Management Inc.
Reporting Jurisdictions: Ceased Reporting

View This Investment Fund's Documents
View this Investment Fund's Group Profile